Methods and apparatus for renal neuromodulation

US9956410B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9956410-B2
Application numberUS-201715636381-A
CountryUS
Kind codeB2
Filing dateJun 28, 2017
Priority dateApr 8, 2002
Publication dateMay 1, 2018
Grant dateMay 1, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.

First claim

Opening claim text (preview).

We claim: 1. A method, comprising: extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves of a hypertensive human patient; and delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves innervating the kidney, wherein delivering electrical energy via the energy delivery elements results in a therapeutically beneficial reduction in blood pressure of the patient. 2. The method of claim 1 wherein extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves comprises delivering the distal segment of the device within an introducer, and wherein the method further comprises at least partially withdrawing the introducer before delivering electrical energy via the energy delivery elements. 3. The method of claim 1 wherein the distal segment of the treatment device comprises a pre-formed spiral shape transformable between (a) a low profile delivery configuration and (b) an expanded configuration that tends to assume the spiral shape and positions the energy delivery elements in contact with tissue at or near the renal nerves before delivering electrical energy via the energy delivery elements. 4. The method of claim 1 wherein extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves comprises inserting the distal segment in proximity to the renal nerves and along a renal blood vessel of the patient. 5. The method of claim 1 wherein extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves comprises delivering the treatment device over a guidewire. 6. The method of claim 1 wherein delivering electrical energy via the energy delivery elements comprises delivering radio frequency (RF) energy to the renal nerves via the plurality of energy delivery elements. 7. The method of claim 6 wherein delivering radio frequency (RF) energy to the renal nerves via the plurality of energy delivery elements comprises delivering RF energy in a monopolar fashion between one or more of the energy delivery elements and an external ground pad attached to an exterior of the patient. 8. The method of claim 1 , further comprising monitoring a parameter of the treatment device and/or tissue within the patient before and during delivery of electrical energy via the energy delivery elements. 9. The method of claim 8 wherein monitoring a parameter comprises monitoring power, temperature, and/or impedance. 10. The method of claim 9 , further comprising altering delivery of the electrical energy in response to the monitored parameter. 11. The method of claim 1 wherein delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves comprises ablating renal nerves of the patient. 12. The method of claim 1 wherein delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves comprises partially ablating renal nerves of the patient. 13. The method of claim 1 wherein delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves reduces neural signaling to and from a kidney of the patient. 14. The method of claim 1 wherein attenuating neural traffic along the renal nerves comprises at least partially denervating a kidney of the patient. 15. The method of claim 1 , further comprising removing the treatment device from the patient after delivering the electrical energy to conclude the procedure. 16. A method for treating a hypertensive human patient, the method comprising: positioning a plurality of electrodes at a distal region of a catheter at an extravascular location within a human patient and adjacent to neural fibers innervating a kidney of the patient; transforming the distal region of the catheter from a low-profile delivery state to an expanded treatment state, wherein, in the treatment state, the distal region of the catheter is sized and shaped to place the plurality of electrodes in contact with target tissue at or near the neural fibers; and ablating the neural fibers innervating the kidney via radio frequency (RF) energy from the electrodes. 17. The method of claim 16 wherein ablating the neural fibers innervating the kidney significantly improves a measurable physiological parameter associated with the hypertension of the patient. 18. The method of claim 16 wherein ablating the neural fibers innervating the kidney results in a therapeutically beneficial reduction in blood pressure of the patient. 19. The method of claim 16 wherein ablating the neural fibers innervating the kidney comprises at least partially denervating the kidney of the patient. 20. The method of claim 16 wherein positioning a plurality of electrodes at a distal region of a catheter at an extravascular location comprises positioning the plurality of electrodes under visual guidance. 21. The method of claim 16 wherein positioning a plurality of electrodes at a distal region of a catheter at an extravascular location comprises positioning the plurality of electrodes under guidance chosen from the group consisting of computed tomographic, radiographic, ultrasonic, angiographic, laparoscopic and combinations thereof.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9956410B2 cover?
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be effic…
Who is the assignee on this patent?
Medtronic Ardian Luxembourg
What technology area does this patent fall under?
Primary CPC classification A61N1/36117. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).